Record-breaking: Scrip analyzes 2013's new product launches
This article was originally published in Scrip
Executive Summary
A host of quadrivalent flu vaccines helped boost the number of new active substances (NASs) launched in their first markets worldwide in 2013 to a record high for this century so far.